Everest Medicines signs new deal targeting drug resistance

Drug Discovery |  News | 0 Comment | 14 Jan, 2019

Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacter...Read more

Janssen submits application to EMA seeking approval of STELARA

Drug Discovery |  News | 0 Comment | 11 Jan, 2019

The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Group Type II Variation Application to the European Medicines Agency (EMA) seeking approval o...Read more

Denali Therapeutics announces Phase 1B Study of DNL747

Drug Discovery |  News | 0 Comment | 11 Jan, 2019

Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases has announced initiation of dosing in a Phase 1b ...Read more

Japan approves Amgen's osteoporosis drug

Drug Discovery |  News | 0 Comment | 10 Jan, 2019

Amgen and UCB  announced that the Japanese Ministry of Health, Labor and Welfare has granted a marketing authorization for EVENITY (romosozumab) for the treatment of osteoporosis in pa...Read more

Daiichi Sankyo receives regulatory approval for hypertension tablets

Drug Discovery |  News | 0 Comment | 10 Jan, 2019

Exelixis, Inc. has announced that its partner Daiichi Sankyo Company, Limited received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for esaxerenone tablets, MINN...Read more

Cellular Biomedicine Initiates clinical trial in anti-BCMA CAR-T therapy

Drug Discovery |  News | 0 Comment | 09 Jan, 2019

Cellular Biomedicine Group Inc., a biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, has announced the initi...Read more

Oculis raises CHF 15.5 million

Drug Discovery |  News | 0 Comment | 08 Jan, 2019

Oculis SA, a clinical-stage biopharmaceutical company developing next-generation topical ophthalmic treatments recently announced that it has successfully raised a further CHF15.5 million i...Read more

AbbVie and Tizona Therapeutics announce strategic collaboration

Drug Discovery |  News | 0 Comment | 04 Jan, 2019

Biopharma company, AbbVie and Biotech company, Tizona Therapeutics has announced that they have entered into a global, strategic collaboration to develop and commercialize CD39-targeted the...Read more

Bristol-Myers Squibb’s Sprycel® tablets now approved for pediatric patients

Drug Discovery |  News | 0 Comment | 04 Jan, 2019

Bristol-Myers Squibb Company has announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ®(dasatinib) tablets to include the treatment of...Read more

AstraZeneca announces phase III trials for roxadustat

Drug Discovery |  News | 0 Comment | 03 Jan, 2019

AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy endpoints for the treatment of patients with anaemia in chronic kidney...Read more

Lupin gets FDA approval for Clobazam oral suspension

Drug Discovery |  News | 0 Comment | 01 Jan, 2019

Pharma major Lupin announced that it has received approval for its Clobazam Oral Suspension, 2.5 mg/mL from the United States Food and Drug Administration (FDA) to market a generic version ...Read more

Teva brings Generic Elidel Cream, 1% in US market

Drug Discovery |  News | 0 Comment | 01 Jan, 2019

Teva Pharmaceutical Industries Ltd., today announced the launch of a generic version of Elidel®1 (pimecrolimus) Cream, 1% in the U.S. Pimecrolimus Cream, 1% is a topical prescript...Read more

BeiGene initiates clinical trial of Tislelizumab with cancer patients

Drug Discovery |  News | 0 Comment | 31 Dec, 2018

BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, ...Read more

Chugai obtains approval for Genomic Mutation Analysis Program

Drug Discovery |  News | 0 Comment | 27 Dec, 2018

Chugai Pharma has announced today that it has obtained regulatory approval from the Ministry of Health, Labour and Welfare (MHLW) for “FoundationOne® CDx Cancer Genomic Profi...Read more

Cannabics files patent for personalized cannabimetic compositions modeling, production

Drug Discovery |  News | 0 Comment | 27 Dec, 2018

Cannabics Pharmaceuticals Inc., a world leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has filed a provisional patent applicatio...Read more

I-Mab gets UDFDA IND nod for exclusive monoclonal antibody TJM2

Drug Discovery |  Company results | 0 Comment | 24 Dec, 2018

I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune disease...Read more

Roivant Sciences, Daiichi Sankyo enter into broad pipeline partnership

Drug Discovery |  News | 0 Comment | 20 Dec, 2018

Roivant Sciences has announced that it has entered into collaboration with Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) to facilitate the out-licensing of investigational med...Read more

Lexicon Pharma announces positive topline clinical data for LX9211

Drug Discovery |  News | 0 Comment | 19 Dec, 2018

Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211, a potent oral small molecule inhibitor of adaptor associated kinase...Read more